Hims & Hers launched an artificial intelligence agent embedded in its platform to help interpret biomarker lab results and ...
SKYSCRAPER-01 trial for tiragolumab and atezolizumab in NSCLC showed numerical improvements but failed to meet primary endpoints for survival. Experts argue that TIGIT remains a promising target, with ...
MedPage Today on MSN
One blood marker is tied to cognition and mortality in people who live past 100
Elevated NfL levels tracked with poorer cognitive scores and higher death risk in centenar ...
Primary care clinicians with higher diagnostic confidence are adopting emerging blood-based Alzheimer’s disease tests, ...
Lucent Diagnostics, a brand of Quanterix Corporation (NASDAQ: QTRX), today announced a collaboration with Tempus AI Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance ...
Vepdegestrant becomes the first FDA-approved heterobifunctional protein degrader (PROTAC) in breast cancer, targeting ER ...
Au8, an experimental ALS therapy. CNM-Au8 has been associated with NfL reductions, a biomarker finding linked to longer ...
Governor Bill Lee signed a bill into law Friday that will require insurance companies to cover biomarker testing.
Blood tests measuring the aging of certain white blood cells can predict cognitive and mood-related symptoms of depression, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results